Essure Birth Control Lawsuit
Essure lawsuits claim Bayer failed to warn patients of severe device side effects. Users suffered uterus perforation, device breakage, autoimmune disorders and fetal death.
At least 39,000 Essure lawsuits have been filed. No settlements have been made.
Why Are Women Filing Essure Lawsuits?
We are helping women sue Bayer after experiencing complications with the company’s Essure sterilization device. Complaints range from problems caused by broken devices, device migration, and even expulsion of the contraceptive implant in some cases.
For more information on the progress of the Essure litigation, check out these excellent articles on our blog:
- Latest Bayer Report Shows Thousands More Essure Adverse Events
- Bayer Indicates Progress in Essure Settlement Talks
- Essure Lawyers Request MDL to Centralize Lawsuits
- Essure Birth Control Lawsuit Settlement
- FDA reviewing complaints about Essure
- Essure: Doctor files death report
- Essure Birth Control Device Blamed for Years of Pain
As part of the complaint, many women are seeking damages for the costs of medical care to treat symptoms and complications of the device’s malfunction, along with related expenses. Many women also are seeking non-economic damages related to pain and suffering, including mental and emotional anguish, as well as punitive damages to punish Bayer for developing, manufacturing, and promoting an unsafe medical device.
See the full, original post here: https://www.consumersafety.org/medical-device-lawsuits/essure/
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement lawsuit loans and post-settlement lawsuit loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation lawsuits, mass tort litigation, and multidistrict litigation. We also provide legal fee funding for attorneys and law firm loans.
|Other Mass Torts||Other MDL Funding|
Click here to see the original article.